@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<http://terminology.hl7.org/CodeSystem/research-study-phase> a fhir:CodeSystem ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "research-study-phase"] ; # 
  fhir:meta [
     fhir:lastUpdated [ fhir:v "2020-04-09T21:10:28.568+00:00"^^xsd:dateTime ]
  ] ; # 
  fhir:text [
     fhir:status [ fhir:v "generated" ] ;
     fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\">Placeholder</div>"
  ] ; # 
  fhir:extension ( [
     fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"^^xsd:anyURI ] ;
     fhir:value [ fhir:v "brr" ]
  ] [
     fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm"^^xsd:anyURI ] ;
     fhir:value [ fhir:v "1"^^xsd:integer ]
  ] ) ; # 
  fhir:url [ fhir:v "http://terminology.hl7.org/CodeSystem/research-study-phase"^^xsd:anyURI] ; # 
  fhir:identifier ( [
     fhir:system [ fhir:v "urn:ietf:rfc:3986"^^xsd:anyURI ] ;
     fhir:value [ fhir:v "urn:oid:2.16.840.1.113883.4.642.1.1247" ]
  ] ) ; # 
  fhir:version [ fhir:v "0.1.0"] ; # 
  fhir:name [ fhir:v "ResearchStudyPhase"] ; # 
  fhir:title [ fhir:v "ResearchStudyPhase"] ; # 
  fhir:status [ fhir:v "draft"] ; # 
  fhir:experimental [ fhir:v "false"^^xsd:boolean] ; # 
  fhir:date [ fhir:v "2020-04-09T21:10:28+00:00"^^xsd:dateTime] ; # 
  fhir:publisher [ fhir:v "HL7 (FHIR Project)"] ; # 
  fhir:contact ( [
     fhir:telecom ( [
       fhir:system [ fhir:v "url" ] ;
       fhir:value [ fhir:v "http://hl7.org/fhir" ]
     ] [
       fhir:system [ fhir:v "email" ] ;
       fhir:value [ fhir:v "fhir@lists.hl7.org" ]
     ] )
  ] ) ; # 
  fhir:description [ fhir:v "Codes for the stage in the progression of a therapy from initial experimental use in humans in clinical trials to post-market evaluation."] ; # 
  fhir:caseSensitive [ fhir:v "true"^^xsd:boolean] ; # 
  fhir:valueSet [
     fhir:v "http://terminology.hl7.org/ValueSet/research-study-phase"^^xsd:anyURI ;
     fhir:link <http://terminology.hl7.org/ValueSet/research-study-phase>
  ] ; # 
  fhir:content [ fhir:v "complete"] ; # 
  fhir:concept ( [
     fhir:code [ fhir:v "n-a" ] ;
     fhir:display [ fhir:v "N/A" ] ;
     fhir:definition [ fhir:v "Trials without phases (for example, studies of devices or behavioral interventions)." ]
  ] [
     fhir:code [ fhir:v "early-phase-1" ] ;
     fhir:display [ fhir:v "Early Phase 1" ] ;
     fhir:definition [ fhir:v "Designation for optional exploratory trials conducted in accordance with the United States Food and Drug Administration's (FDA) 2006 Guidance on Exploratory Investigational New Drug (IND) Studies. Formerly called Phase 0." ]
  ] [
     fhir:code [ fhir:v "phase-1" ] ;
     fhir:display [ fhir:v "Phase 1" ] ;
     fhir:definition [ fhir:v "Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients." ]
  ] [
     fhir:code [ fhir:v "phase-1-phase-2" ] ;
     fhir:display [ fhir:v "Phase 1/Phase 2" ] ;
     fhir:definition [ fhir:v "Trials that are a combination of phases 1 and 2." ]
  ] [
     fhir:code [ fhir:v "phase-2" ] ;
     fhir:display [ fhir:v "Phase 2" ] ;
     fhir:definition [ fhir:v "Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks." ]
  ] [
     fhir:code [ fhir:v "phase-2-phase-3" ] ;
     fhir:display [ fhir:v "Phase 2/Phase 3" ] ;
     fhir:definition [ fhir:v "Trials that are a combination of phases 2 and 3." ]
  ] [
     fhir:code [ fhir:v "phase-3" ] ;
     fhir:display [ fhir:v "Phase 3" ] ;
     fhir:definition [ fhir:v "Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug." ]
  ] [
     fhir:code [ fhir:v "phase-4" ] ;
     fhir:display [ fhir:v "Phase 4" ] ;
     fhir:definition [ fhir:v "Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use." ]
  ] ) . # 

# -------------------------------------------------------------------------------------